Varicella vaccination in Germany: A provisional appraisal in the context of MMR vaccination;Die Varizellenimpfung in Deutschland: Eine Zwischenbilanz mit Blick auf die Masern-Mumps-Röteln- (MMR-)Impfung

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 56, Issue 9, 2013, Pages 1313-1320

  Siedler, A ^a   Hecht, J ^a   Rieck, T ^a,b   Tolksdorf, K ^a   Hengel, H ^c  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Herpes zoster; MMR vaccination; Surveillance; Vaccination goal; Varicella vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; DISEASE ERADICATION; ENDEMIC DISEASE; FEMALE; GERMANY; HUMAN; INCIDENCE; INFANT; MALE; MASS IMMUNIZATION; METHODOLOGY; PRESCHOOL CHILD; RISK ASSESSMENT; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; CHICKENPOX; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; ENDEMIC DISEASES; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; MALE; MASS VACCINATION; MEASLES-MUMPS-RUBELLA VACCINE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84884234875     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-013-1789-z     Document Type: Article

References (33)

1. Brisson M, Edmunds WJ, Gax NJ et al (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125:19
2. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20:8
3. Hoehle M, Siedler A, Bader HM et al (2011) Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect 139:10
4. Jumaan AO, Yu O, Jackson LA et al (2002) Incidence of herpes zoster, before and after varicella-vaccination - associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 191:6
5. Khandaker G, Marshall H, Peadon E et al (2011) Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child 96:4
6. Leung J, Harpaz R, Molinari NA et al (2011) Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 52:9
7. Lopez AS, Kolasa MS, Seward JF (2008) Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program. J Infect Dis 197:6
8. Marin M, Watson TL, Chaves SS et al (2008) Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 197:7
9. Nguyen MD, Perella D, Watson B et al (2010) Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in philadelphia, pennsylvania, 2006. Pediatr Infect Dis J 29:5
10. Reuss AM, Feig M, Kappelmayer L et al (2010) Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health 10:7
11. Robert-Koch-Institut (2012) Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2010. Epid Bull 16:5
12. Robert-Koch-Institut SurvStat@RKI (o J) Abfrage der Meldedaten nach Infektionsschutzgesetz (IfSG) über das Web. http://www.rki.de/DE/Content/ Infekt/SurvStat/survstat-node.html
13. Robert-Koch-Institut (2008) Zur Sentinel-Surveillance der Varizellen in Deutschland. Epid Bull 8:9
14. Seward J, Watson B, Peterson C et al (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287:6
15. Siedler A, Arndt U (2010) Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill 15:7
16. Siedler A, Grueber A (2012) Effect of second varicella vaccine dose on breakthrough cases in Germany - preliminary results from sentinel surveillance. 30th Annual Meeting of the European Society For Paediatric Infectious Diseases
17. Siedler A, Rieck T, Reuss A et al (2012) Estimating vaccination coverage in the absence of immunisation registers - the German experience. Euro Surveill 17:7
18. Spackova M, Muehlen M, Siedler A (2010) Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J 29:3
19. Spackova M, Wiese-Posselt M, Dehnert M et al (2010) Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine 28:6
20. Statistisches-Bundesamt (o J) Das Informationssystem der Gesundheitsberichterstattung des Bundes. http://www.gbe-bund.de
21. STIKO (2004) Begründung der STIKO für eine allgemeine Varizellenimpfung. Epid Bull 49:4
22. STIKO (2012) Empfehlungen der Ständigen Impfkommision. Stand Juli 2012. Epid Bull 30:28
23. STIKO (2004) Empfehlungen der Ständigen Impfkommission, Stand Juli 2004. Epid Bull 30:16
24. STIKO (2006) Empfehlungen der Ständigen Impfkommission, Stand Juli 2006. Epid Bull 30:20
25. STIKO (2009) Empfehlungen der Ständigen Impfkommission, Stand Juli 2009. Epid Bull 30:20
26. STIKO (2008) Mitteilung der Ständigen Impfkommission (STIKO) am RKI zur Impfung gegen Varizellen. Epid Bull 41:1
27. STIKO (2011) Mitteilung der Ständigen Impfkommission: Zur Kombinationsimpfung gegen Masern, Mumps, Röteln und Varizellen (MMRV). Epid Bull 38:2
28. Tan B, Bettinger J, McConnell A et al (2012) The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatr Infect Dis J 31:8
29. Thiele S, Borschewski A, Küchler J et al (2011) Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions. Clin Vaccine Immunol 18:9
30. Tillieux SL, Halsey WS, Thomas ES et al (2008) Complete DNA sequences of two oka strain varicella-zoster virus genomes. J Virol 82:12
31. Hoek AJ van, Melegaro A, Zagheni E et al (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 29:10
32. Yih WK, Brooks DR, Lett SM et al (2005) The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 5:9
33. Streng A, Grote V, Carr D, Hagemann C, Liese JG (2013) Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis 2;13(1):303